Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000919574-26-007567·CYBIN INC.
Schedule 13G ownership disclosure
Helus Pharma Inc
Common Shares, no par value · CUSIP: 423492107
Event date: 2026-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Adage Capital Management, L.P.
Shares: 5,479,250.00 · Class: 7.48%
- Robert Atchinson
Shares: 5,479,250.00 · Class: 7.48%
- Phillip Gross
Shares: 5,479,250.00 · Class: 7.48%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000919574-26-007567
- Form type
- SCHEDULE 13G/A
- Filer
- CYBIN INC.
- CIK
- CIK 1833141
- Filed
- Nov 12, 2026
- Reporting period
- Sep 30, 2026
- Description
- Schedule 13G beneficial ownership